BCV is a French Medtech startup
developing a solution to optimize endovascular navigation
The first generation actuable mechatronic guide wire designed to provide practitioners with a direct access and navigation during minimally invasive endovascular procedures.
Co-Founded in 2016 by Dr Raphaël Blanc (President, deputy-head of the interventional neuroradiology department at the Rothschild Foundation Hospital, Paris, France), Jean-Baptiste Cazeneuve (CTO, Mechatronic Engineer), Jérôme Szewczyk (Researcher at the Institute of Intelligent Systems and Robotics ISIR, Professor at Sorbonne University, Teacher at Polytech Sorbonne) and Michel Boulaire (Strategy consultant, expert in corporate governance with over 30 years of experience).
BCV’s disruptive technology uses Shape Memory Alloy actuators optimizing the navigation through vascular tortuosities.
A unique smart handle with electronic control of shape-memory actuation of the guidewires for management of tortuous vessels.
The local actuation on tip, with specific curves, engineered with Shape Memory Alloys actuators has the potential to make procedures fast, safe and robotically controlled.
This is compatible with all the leading catheter solutions used in stroke endovascular treatments.
Compatible with existing treatment catheters and image-guided platforms, this guidewire system is also compatible with Robotics, Artificial Intelligence and Data in a patient-oriented specific design.
I-NOV 2022 LAUREATE
Our project “Active guidewires for endovascular access and navigation” is one of the 14 laureates of the I-Nov Innovation contest (2022) and is financed by France 2030 and by the European Union – Next Generation EU – as part of the France Relance plan.
Our actuable mechatronic guidewire was developed with help from the Institute of Intelligent Systems and Robotics (ISIR) at Sorbonne University – CNRS – INSERM & the Rothschild Foundation Hospital.
BCV is supported by
BCV IS MEMBER OF
BCV'S OBJECTIVE IS TO IMPROVE PATIENT OUTCOMES BY OPTIMIZING
THE ACCESS & NAVIGATION DURING MINIMALLY INVASIVE ENDOVASCULAR PROCEDURES